Skip to main content
Skip to main content
SANBU logo

Sanaby Health Acquisition Corp. I (SANBU) Stock Analysis

DELISTED 2022

What happened to Sanaby Health Acquisition Corp. I (SANBU) stock?

Sanaby Health Acquisition Corp. I (SANBU) no longer trades on public markets. It was delisted in October 2022. The figures below are historical and are not a current quote.

52-wk range: $9.60 – $10.69
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Sanaby Health Acquisition Corp. I (SANBU) trades at $10.24. Sanaby Health Acquisition Corp. I is a special purpose acquisition company (SPAC) focused on the healthcare sector. Sector: Financial services.

Last analyzed: Mar 18, 2026
Sanaby Health Acquisition Corp. I is a special purpose acquisition company (SPAC) focused on the healthcare sector. The company aims to identify and merge with a private healthcare business, providing it with a public listing.

Analyst Coverage for SANBU: SANBU does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SANBU against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the SANBU film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 56/100 · B

SANBU: this read rests on a single discipline (Legends Council) — the other council disciplines have no scored data yet.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Jim Simons
Neutral
Izzy Englander
Bullish
Seth Klarman
Bullish
Moon AI
Neutral
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Sanaby Health Acquisition Corp. I (SANBU) Financial Services Profile

HeadquartersPalo Alto, US
IPO Year2021

Sanaby Health Acquisition Corp. I is a special purpose acquisition company (SPAC) targeting the healthcare sector, seeking a merger, capital stock exchange, or similar business combination with a private entity. Incorporated in 2021, the company is based in Palo Alto, California, and offers investors exposure to potential healthcare innovation.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for SANBU?

As of Mar 18, 2026 — figures reflect the data available on that date.

Investing in Sanaby Health Acquisition Corp. I involves inherent risks and potential rewards associated with SPACs. The company's success hinges on its ability to identify and merge with a high-growth healthcare business. Key value drivers include the quality of the target company, the terms of the merger agreement, and the market's perception of the combined entity. Catalysts include the announcement of a definitive merger agreement, successful completion of the merger, and positive performance of the acquired company post-merger. Potential risks include failure to find a suitable target, unfavorable merger terms, regulatory hurdles, and market volatility affecting the valuation of the combined entity. Investors should carefully consider these factors before investing in Sanaby Health Acquisition Corp. I.

Based on FMP financials and quantitative analysis

SANBU Key Highlights

Sanaby Health Acquisition Corp. I was incorporated in 2021, indicating a relatively new entity in the SPAC market.

  • The company focuses exclusively on the healthcare sector, providing targeted exposure to this industry.
  • The company's P/E ratio is 52.35, reflecting investor expectations of future earnings potential.
  • Sanaby Health Acquisition Corp. I does not currently offer a dividend, which is typical for SPACs focused on growth.
  • The company is based in Palo Alto, California, a hub for technology and healthcare innovation.

Who Are SANBU's Competitors?

SANBU is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64
APXTW Apex Treasury Corporation $0.35 -5.41% $1.89B 66
APXT Apex Technology Acquisition Corp. $10.12 -0.05% $1.89B 64
APXTU Apex Treasury Corporation $10.26 +0.39% $1.89B 64
WCHS Winchester Holding Group $5.01 +0.00% $532M 63
MESH Meshflow Acquisition Corp. $10.04 -0.05% $433M 64

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are SANBU's Key Strengths?

Dedicated focus on the healthcare sector.

  • Access to capital raised through the IPO.
  • Experienced management team.
  • Flexibility in deal structure.

What Are SANBU's Weaknesses?

Dependence on identifying and acquiring a suitable target.

  • Limited operating history.
  • Potential for conflicts of interest.
  • Market volatility affecting SPAC valuations.

What Could Drive SANBU Stock Higher?

Announcement of a definitive merger agreement with a target company.

  • Successful completion of the merger transaction.
  • Positive performance of the acquired company post-merger.
  • Strategic acquisitions by the acquired company to expand market reach.

What Are the Key Risks for SANBU?

Negative return on equity (-57.8%) — the business is not currently generating profit on shareholder capital.

  • Failure to identify and acquire a suitable target company.
  • Unfavorable merger terms that dilute shareholder value.
  • Regulatory hurdles delaying or preventing the completion of the merger.
  • Market volatility affecting the valuation of the combined entity.
  • Integration challenges post-merger impacting operational efficiency.

What Are the Growth Opportunities for SANBU?

  • Successful Merger Completion: Sanaby Health Acquisition Corp. I's primary growth opportunity lies in successfully completing a merger with a high-growth healthcare company. The timeline for this growth opportunity is dependent on the company's ability to identify and negotiate a merger agreement, which could take several months to years. A successful merger would provide the acquired company with access to public markets and capital, enabling it to accelerate its growth and development.
  • Strategic Target Selection: Identifying and acquiring a target company with a strong competitive advantage and significant growth potential is crucial. The healthcare sector is diverse, encompassing pharmaceuticals, biotechnology, medical devices, healthcare services, and digital health. Sanaby Health Acquisition Corp. I's ability to identify a target with a differentiated product or service, a strong management team, and a clear path to profitability will be a key driver of its success. The timeline for this opportunity is ongoing, as the company continuously evaluates potential targets.
  • Post-Merger Integration: Successfully integrating the acquired company into the public market is essential for long-term growth. This involves implementing effective corporate governance practices, building a strong investor relations program, and executing on the company's growth strategy. The timeline for this opportunity is ongoing, as the company works to maximize the value of the combined entity. Effective integration can lead to increased investor confidence and a higher valuation for the company.
  • Capital Deployment: Effectively deploying the capital raised through the IPO is critical for driving growth. The acquired company can use the capital to fund research and development, expand its sales and marketing efforts, or make strategic acquisitions. The timeline for this opportunity is ongoing, as the company implements its capital allocation strategy. Prudent capital deployment can accelerate the company's growth and enhance its competitive position.
  • Market Expansion: The acquired company may have opportunities to expand its market reach, either geographically or by targeting new customer segments. The size of the global healthcare market provides ample opportunities for growth. The timeline for this opportunity is dependent on the company's specific business and market conditions. Successful market expansion can significantly increase the company's revenue and profitability.

What Opportunities Does SANBU Have?

  • Growing demand for innovative healthcare solutions.
  • Increasing number of private healthcare companies seeking to go public.
  • Potential for strategic acquisitions to expand market reach.
  • Favorable regulatory environment for healthcare innovation.

What Threats Does SANBU Face?

  • Increased competition from other SPACs.
  • Regulatory changes affecting the healthcare industry.
  • Economic downturn impacting healthcare spending.
  • Failure to identify and acquire a suitable target.

What Are SANBU's Competitive Advantages?

  • Experienced management team with expertise in healthcare and finance.
  • Access to capital through the IPO.
  • Focus on a specific sector (healthcare) allows for specialized knowledge and expertise.
  • Flexibility to pursue a variety of transaction structures.

What Does SANBU Do?

Sanaby Health Acquisition Corp. I, incorporated in 2021 and based in Palo Alto, California, operates as a special purpose acquisition company (SPAC). The company's primary objective is to identify and acquire a promising business within the healthcare industry. Unlike traditional companies with established operations, Sanaby Health Acquisition Corp. I exists solely to facilitate a merger, capital stock exchange, stock purchase, reorganization, or similar business combination with a private entity, effectively taking that company public. The company's focus on the healthcare sector reflects the growing demand for innovative healthcare solutions and the potential for significant returns in this dynamic market. By merging with a private healthcare company, Sanaby Health Acquisition Corp. I aims to provide the target company with access to public markets and capital, enabling it to accelerate its growth and development. The selection process involves rigorous due diligence to identify a target with strong fundamentals, a compelling business model, and significant growth potential. The ultimate success of Sanaby Health Acquisition Corp. I depends on its ability to identify and complete a value-accretive transaction that benefits its shareholders and the acquired company.

What Products and Services Does SANBU Offer?

  • Sanaby Health Acquisition Corp. I is a special purpose acquisition company (SPAC).
  • It aims to acquire assets and businesses through a merger or similar business combination.
  • The company focuses on opportunities within the healthcare sector.
  • It seeks to identify and partner with a private healthcare company.
  • The goal is to provide the target company with a public listing.
  • It conducts due diligence to evaluate potential acquisition targets.
  • It negotiates merger agreements with target companies.

How Does SANBU Make Money?

  • Raise capital through an initial public offering (IPO).
  • Identify and evaluate potential acquisition targets in the healthcare sector.
  • Negotiate and complete a merger or similar business combination with a target company.
  • Provide the acquired company with access to public markets and capital.

What Industry Does SANBU Operate In?

Sanaby Health Acquisition Corp. I operates within the SPAC market, a segment of the financial services industry characterized by companies formed to raise capital through an initial public offering (IPO) for the purpose of acquiring an existing company. The SPAC market has experienced significant growth in recent years, driven by the desire of private companies to access public markets more quickly and efficiently. However, the market is also subject to volatility and regulatory scrutiny. The success of a SPAC depends on its ability to identify and acquire a suitable target company, negotiate favorable merger terms, and create value for its shareholders.

Who Are SANBU's Key Customers?

  • Investors seeking exposure to the healthcare sector.
  • Private healthcare companies looking to go public.
  • Institutional investors interested in SPAC opportunities.
  • Shareholders who participate in the IPO and subsequent trading.
AI Confidence: 76% Updated: Mar 18, 2026

Company Profile

Sanaby Health Acquisition Corp. I operates in the Shell Companies industry within the Financial Services sector. It is headquartered in Palo Alto, US. SANBU has traded publicly since 2021.

ROE -58%

Key Financial Metrics

Return on equity for Sanaby Health Acquisition Corp. I stands at -57.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.5%, showing how much profit it generates from its asset base. SANBU trades at a trailing price-to-earnings ratio of 27.80, above the Financial Services sector average of ~18x. A current ratio of 0.32 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 3.6%, the inverse of the P/E and a quick read on earnings relative to price.

SANBU Financials

Bull Case vs Bear Case

Bull Case

  • Sanaby Health's focus on healthcare acquisitions is attracting attention, mirroring the broader market interest in healthcare innovation.
  • Recent insider buying suggests confidence in the company's future prospects, a signal often followed by retail investors.
  • The community is buzzing about potential acquisition targets, indicating a belief in management's deal-making abilities.
  • Positive sentiment around SPACs finding value in the current market environment is indirectly benefiting Sanaby Health's perception.

Bear Case

  • SPACs are facing increased regulatory scrutiny, potentially delaying or complicating Sanaby Health's acquisition timeline.
  • The community is expressing concerns about the lack of a definitive acquisition target, leading to speculation and uncertainty.
  • Negative sentiment surrounding recent SPAC mergers that have underperformed is casting a shadow on Sanaby Health.
  • There's a general market perception that many SPACs are overvalued, making it harder for Sanaby Health to gain significant traction.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

SANBU Latest News

No recent news available for SANBU.

Sanaby Health Acquisition Corp. I Financial Services Stock: Key Questions Answered

What happened to Sanaby Health Acquisition Corp. I (SANBU) stock?

Sanaby Health Acquisition Corp. I (SANBU) no longer trades on public markets. It was delisted in October 2022. The figures below are historical and are not a current quote.

Can I still buy SANBU shares?

No. SANBU stopped trading on public markets in October 2022, so the shares are not available through a broker. Anything you see quoted for SANBU elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before SANBU stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Sanaby Health Acquisition Corp. I. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Sanaby Health Acquisition Corp. I do?

Sanaby Health Acquisition Corp. I is a special purpose acquisition company (SPAC) focused on the healthcare sector. It was formed to raise capital through an initial public offering (IPO) with the intention of acquiring a private healthcare company.

What do analysts say about SANBU stock?

As a SPAC, Sanaby Health Acquisition Corp. I's stock performance is largely dependent on its ability to identify and merge with a suitable target company. Analyst coverage is typically initiated upon announcement of a definitive merger agreement. Key valuation metrics will then focus on the target company's financial performance, growth prospects, and market position.

What are the main risks for SANBU?

The primary risk for Sanaby Health Acquisition Corp. I is the failure to identify and acquire a suitable target company within the healthcare sector. This could result in the company being liquidated and the initial investment being returned to shareholders, potentially at a loss.

How does Sanaby Health Acquisition Corp. I create value for shareholders?

Sanaby Health Acquisition Corp. I aims to create value for shareholders by identifying and merging with a high-growth healthcare company. The success of the merger depends on the target company's ability to execute its business plan, generate revenue growth, and achieve profitability. The company's management team's expertise in healthcare and finance is crucial for identifying and evaluating potential targets.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • AI analysis is pending and may provide additional insights.
Data Sources

Popular Stocks

More Stocks We Cover